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Trichain Cationic Lipids: The Potential of their Lipoplexes for Gene 
Delivery 
Laila Kudsiova,a,d,† Atefeh Mohammadi,b,† M. Firouz Mohd Mustapa,b  Frederick Campbell,b 
Katharina Welser,b Danielle Vlaho,b Harriet Story,b David J. Barlow,a Alethea B. Tabor,b Helen C. 
Hailesb,* and  M. Jayne Lawrencea,c * 
Lipoplexes (LDs) have been prepared from DNA and positively charged vesicles composed of the helper lipid, dioleoyl L-α-
phosphatidylethanolamine (DOPE) and either a dichain (DC) oxyethylated cationic lipid or their corresponding novel trichain 
(TC) counterpart. This is the first study using the TC lipids for the preparation of LDs and their application. Here the results 
of biophysical experiments characterising the LDs have been correlated with the in vitro transfection activity of the 
complexes. Photon correlation spectroscopy, zeta potential measurements and transmission electron microscopy studies 
indicated that, regardless of the presence of a third chain, there were little differences between the size and charge of the 
TC and DC containing LDs. Small angle neutron scattering studies established however that there was a significant 
conformational re-arrangement of the lipid bilayer when in the form of a LD complex as opposed to the parent vesicles. This 
re-arrangement was particularly noticeable in LDs containing TC lipids possessing a third chain of C12 or a longer chain. These 
results suggested that the presence a third hydrophobic chain had a significant effect on lipid packing in the presence of 
DNA. Picogreen fluorescence and gel electrophoresis studies showed that the TC lipids containing a third acyl chain of at 
least C12 were most effective at complexing DNA while the TC lipids containing an octanoyl chain and the DC lipids were least 
effective. The transfection efficacies of the TC lipids in the form of LDs were found to be higher than for the DC analogues, 
particularly when the third acyl chain was an octanoyl or oleoyl moeity. Little or no increase in transfection efficiency was 
observed when the third chain was a methyl, acetyl or dodecanoyl group. The large enhancement in transfection 
performance of the TC lipids can be attributed to their ability to complex their DNA payload. These studies indicate that 
presence of a medium or long third acyl chain was especially beneficial for transfection. 
 
Introduction 
Lipoplexes (LDs) formed from the complexation of positively charged 
vesicles formed by synthetic cationic lipids (or cytofectins), alone and 
in the presence of a neutral co- (or helper) lipid, and negatively 
charged DNA have been amongst the most widely studied of non-
viral vectors.1 Interest in LDs stems from their low immunogenicity, 
their ease of preparation and handling and, importantly their ability 
to be targeted to specific cell types in the body.2,3 Unfortunately the 
commercial exploitation of LDs has been impeded largely because of 
their low transfection ability, especially when compared to viral 
vectors.3 In an attempt to overcome this limitation, research groups, 
including our own, have synthesized novel cationic lipids with a view 
to preparing LDs with an improved transfection ability.4-7 These 
studies have demonstrated that it is possible to get improved 
transfection activity through the careful selection of the cationic lipid 
used and optimisation of the LD formulation, in particular the charge 
ratio, type and ratio of neutral co-lipid added and whether the 
cationic lipid is PEGylated. However, further improvement in 
transfection ability is required if LDs are to prove to be a realistic, 
viable alternative to viral vectors. 
The present work examines the biophysical and transfection 
properties of LDs formed using one of two groups of hydroxyl 
terminated short n-ethylene glycol (oxyethylated dichain (DC) 
derivatives) lipids or their corresponding trichain (TC) counterparts 
(Table 1). The synthesis of the Group 1 and 2 lipids, together with the 
biophysical and in vitro transfection ability of lipopolyplexes (LPDs) 
formulated from these lipids has been detailed in Mohammadi et al.8 
Of importance to the present study the TC lipid containing LPDs 
demonstrated an enhancement in transfection performance 
compared to LPDs containing the corresponding DC lipids.8 It was of 
interest whether a similar enhancement in transfection efficiency 
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could be achieved with LDs prepared using the same novel lipids and 
these were examined in the present study. 
Table 1. Summary of the dichain and trichain lipid prepared (Group 1 lipids) and dichain 
lipids capped with different ester chain lengths (Group 2 lipids).8 
 
DOTMA-based 
ether series 
 DOTAP-based 
ester series 
 
Group 1 lipids: 
 
   
DODEG4 
 
DOesDEG4 
 
TC-DODEG4 
 
TC-DOesDEG4 
 
  Me-DOesDEG3 
 
DOSEG3 
 
DOesSEG3 
 
TC-DOSEG3 
 
TC-DOesSEG3 
 
  Me-DOesSEG3 
 
TC-DHSEG3 
 
   
Group 2 lipids: 
 
   
AC-DODEG4 
 
AC-DOesDEG4 
 
OC-DODEG4  
 
 
  
DO-DODEG4  
 
 
DO-DOesDEG4  
TC-DODEG4 
 
TC-DOesDEG4 
 
 ether lipid;  ester lipid;             C18-chain;         C16-chain;     acetyl group 
octanoyl group                   dodecanoyl group         
                 3-PEG          Me capped 3-PEG          4-PEG 
 directly linked        longer cleavable linker 
 
In Group 1 lipids, the cationic moieties of the DC variants were 
terminated with a short n-ethylene glycol (n-EG) chain, which itself 
contained either a free hydroxyl group or was capped with a methoxy 
group. In the corresponding Group 1 TC lipids, the terminal hydroxyl 
group was terminated by an unsaturated C18 fatty acid. In Group 1 
we were therefore able to explore the effect of the presence of an 
extra oleoyl chain on in vitro transfection. The only exception to this 
was TC-DHSEG3 where two C16:1 chains replaced the C18:1 lipidic 
chains. In the Group 2 TC cationic lipids,  the effect of varying the 
length of the third fatty acid from acetyl through octanoyl and 
dodecanoyl to oleoyl was explored, while keeping the two chains as 
C18:1. The parent structure of the DC ether and ester lipids were the 
DOTMA and DOTAP motifes, respectively. respectively. All lipids 
contained only a single cationic charge and were prepared as the 
bromide salts. 
The molecular structure of the novel cationic lipids is described 
by a short letter code (Table 1). When the prefix TC- is used, the lipid 
is a TC lipid, whereas when no prefix is present, the lipid is a dichain 
(DC) lipid. The nature of the acyl chains on the basic DC lipid is 
indicated by the letters DO when two oleyl chains are present and 
DH when hexadecenyl chains are present. The nature of the third 
chain when present is described by AC, OC or DO, for acetyl, octanoyl 
or dodecanoyl groups, respectively. The molecular structure of the 
cationic lipids was varied by altering the linking group to the glycerol 
backbone, either an ester (described using es) or an ether moiety. 
Similarly, the nature of the group attaching the cationic head group 
to the n-ethylene glycol component was varied, being either a short 
ester spacer (S) or direct attachment of the glycol unit to the 
dimethylammonium cation (D). The short ethylene glycol chain 
present in all the lipids was indicated by either EG3 or EG4 depending 
upon the length of the chain. 
The present paper reports the transfection efficiency and the 
biophysical properties of the LDs formed by a series of novel TC lipids 
and their corresponding DC lipids and relates them to lipid molecular 
structure. A detailed and comprehensive understanding of which 
molecular features are important for transfection is a prerequisite 
for the development of pharmaceutically sound and efficient LDs. 
The interaction of vesicles containing these novel cationic lipids in 
combination with a 1:1 molar ratio of dioleoyl L-α-
phosphatidylethanolamine (DOPE) with DNA (either plasmid or calf 
thymus) was investigated using several biophysical techniques and 
the biophysical properties of the resulting LDs then correlated with 
their in vitro lipofection activity. The properties of LDs formed using 
the Group 1 and Group 2 TC lipids were of particular interest in the 
present study because of the major enhancement in cellular 
transfection performance observed with LPDs formulated containing 
these novel TC lipids. Significantly, to our knowledge in this study it 
is the first time that TC lipids have been used for the preparation of 
LDs. 
Results 
Biophysical characterisation of the vesicles 
Vesicles: photon correlation spectroscopy and zeta potential 
measurements 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3  
Please do not adjust margins 
Please do not adjust margins 
The formation and characterisation of vesicles prepared by DOTMA 
and DOTAP and their n-EG DC and TC derivatives (i.e. Group 1 and 2 
lipids) when in combination with a 1:1 molar ratio of DOPE using 
photon correlation spectroscopy, zeta potential, electron 
microscopy and small angle neutron scattering will be reported 
elsewhere.8 In this earlier study it was reported that it was not 
possible to form vesicles using DO-DODEG4 or its ester equivalent 
DO-DOesDEG4 when in combination with a 1:1 molar ratio of DOPE. 
It did, however, prove possible to prepare stable vesicles from both 
of these lipids when used in combination with a 1:1 molar ratio of 
DOPC. This interesting observation is in agreement with the known 
tendency of DOPE to form non-bilayer structures.9 All the data 
reported here are therefore using DO-DODEG4 and DO-DOesDEG4 in 
LDs prepared from vesicles containing 50 mol% DOPC in place of 
DOPE. Furthermore, It should be noted that earlier SANS, TEM and 
size measurement experiments on similar complexes showed no 
difference in the internal structure or the size/shape of lipoplexes, 
when plasmid DNA or calf thymus DNA (ctDNA) were used.6 ctDNA 
was therefore used in experiments requiring large amounts of DNA, 
where the use of plasmid was not practical.  
Figure 1(a) illustrates the apparent hydrodynamic size of the LD 
vesicles formed using the Group 1 and 2 lipids. As can be seen, the 
apparent hydrodynamic sizes of the parent vesicles, assuming the 
presence of spherical particles, were in the range 45 - 80 nm. The 
vesicles were stable with respect to size for a period of at least a 
week (Figure 1(a)) and generally up to one month (Figure 1, SI). It 
should be noted that vesicles were prepared from the DC and TC-
lipids on a number of occasions and while the vesicle size fell within 
the range quoted above, there was no reproducible trend in the 
relationship between lipid structure and vesicle size – except for the 
size of the TC-lipids which tended to form vesicles at the upper end 
of the size range. The relatively small size of the vesicles (i.e. all < 100 
nm), indicated that they were likely to be predominately unilamellar 
in nature, particularly those containing DC-lipids which were at the 
lower end of the vesicle size range. It is not possible however to 
exclude the presence of minor populations of multilamellar vesicles 
within the vesicle preparations. 
 A limited study was performed to look at the effect of pH (either 
7.4 or 5) on the size of the vesicles formed by a selection of DC and 
TC lipids, namely DODEG4, TC-DODEG4, DOSEG3 and TC-DOSEG3 in 
combination with a 1:1 molar ratio of DOPE. As expected (Figure 2, 
SI) there was no relationship between vesicle size and pH of the 
aqueous solvent used for its preparation. All vesicles possessed a 
zeta potential of at least ~ 40 mV (Figure 1b) supporting the good 
stability observed with the vesicles by photon correlation 
spectroscopy. Indeed, the vesicles were stable with respect to zeta 
potential for a period of up to one month (Figure 1, SI). Again, there 
was no clear trend between lipid type and vesicle zeta potential, with 
the absolute value determined varying slightly each time the vesicles 
were prepared. 
 
 
 
Figure 1. (a) the apparent hydrodynamic size (nm) of vesicles on the day 
of their preparation (day 1) (black bars) and 7 days after their 
preparation (day 7) (grey bars) and (b) the zeta potential (mV) of the 
same vesicles measured on the day of their preparation. All vesicles 
were prepared from cationic lipids in combination with DOPE or (*) 
DOPC at a cationic lipid concentration of 0.01 mg/mL. Measurements 
were performed at 298 ± 0.1 K. in triplicate and shown as the mean 
value ± standard deviation. 
 
Vesicles: small angle neutron scattering  
Table 2 gives the structural parameters used to obtain the best fit to 
the small angle neutron scattering (SANS) data for freshly prepared 
vesicles containing 50 mol% DOPE and a novel cationic lipid (Group 1 
or Group 2) at cationic lipid concentrations of 1 mg/mL. Despite their 
small apparent hydrodynamic size, the vesicles were well modelled 
as single, flat sheets (or bilayers) with or without the presence of 
(multilamellar) stacks. The use of a flat sheet model to analyse the 
SANS data here is in agreement with earlier SANS studies on vesicles 
of comparable hydrodynamic size.10,11 An example of the SANS 
profile recorded for the vesicles prepared by the dichain cationic lipid 
(Me-DOesDEG3) and DOPE along with the best fit to the data 
obtained using a flat sheet model is shown in Figure 3, SI. 
Significantly, the SANS studies on the vesicles indicated that, 
regardless of the chemical structure of the novel lipid, the 
thicknesses of the various vesicle bilayers were in the range 3.8 -4.3 
nm. When the presence of bilayer stacks were required to model the 
data, the proportion of multilamellar vesicles was very low 
(supporting the presence of a predominately unilamellar vesicle 
population), while the measured repeat distance was 5.7 - 5.8 nm 
(a) 
(b) 
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with the exception of a couple of the Group 1 TC lipids (TC-DOesDEG4 
and TC-DOesSEG3) where a slightly larger repeat was observed 
(Table 2).  There was no correlation in the thickness of the bilayer 
with lipid structure – namely bond type (ester or ether), length of the 
n-EG linker and the absence/presence of a third chain irrespective of 
its length. As a consequence of the similarity of the parameters 
obtained for the vesicles, it was concluded that TC lipid-containing 
aggregates prepared under the conditions used were vesicular. 
Reassuringly, the parameters obtained from fitting the SANS results 
of the vesicles in this study are similar to those reported for the LPD 
systems.8 
 
Table 2. Structural parameters obtained through model fitting of the small 
angle neutron scattering data recorded at 298 ± 0.1 K for freshly prepared 
cationic vesicles containing the novel lipids together with a 1:1 molar ratio of 
DOPE or (*) DOPC (V) at a cationic lipid concentration of 1 mg/mL, and 
corresponding lipoplexes (LD) prepared from the vesicles and ctDNA at a L:D 
charge ratio of 2:1 at a cationic lipid concentration of 0.1 mg/mL 
 
Cationic lipid L (nm) D (nm) 
DOTMA V4.2 ± 0.1 
LD4.2 ± 0.2 
V6.2 ± 0.1 
LD6.5 ± 0.1 
DODEG4 V4.1 ± 0.1 
LD5.4 ± 0.2 
ND 
LD6.4± 0.2 
TC-DODEG4 V4.2 ± 0.1† 
LD12.7 ± 0.3 
V5.8 ± 0.1† 
LD14.3 ± 0.1 
DOSEG3 V4.2 ± 0.1 
LD4.9 ± 0.2 
ND 
LD5.8 ± 0.1 
TC-DOSEG3 V4.1 ± 0.1 
LD10.3 ± 0.2 
V5.7 ± 0.1 
LD13.5 ± 0.1 
TC-DHSEG4 V4.2 ± 0.1 
LD11.3 ± 0.1 
V5.8 ± 0.1 
LD14.0 ± 0.1 
DOTAP V4.0 ± 0.1 
LD4.1 ± 0.2 
V6.1 ± 0.1 
LD6.0 ± 0.1 
DOesDEG4 
 
V3.9 ± 0.1 
LD5.4 ± 0.2 
V5.7 ± 0.1 
LD6.4 ± 0.1 
TC-DOesDEG4 V4.1 ± 0.1 
LD10.7 ± 0.4 
V6.5 ± 0.3 
LD14.3 ± 0.1 
Me-DOesDEG3 V4.0 ± 0.1‡ 
LD5.4 ± 0.5 
V5.7 ± 0.1‡ 
LD6.4 ± 0.1 
DOesSEG3 V3.8 ± 0.1 
LD5.3 ± 0.3 
V5.7 ± 0.1 
LD6.5 ± 0.1 
TC-DOesSEG3 V4.3 ± 0.1 
LD10.3 ± 0.4 
V6.0 ± 0.1 
LD13.5 ± 0.1 
Me-DOesSEG3 V4.0 ± 0.1‡  
LD5.4 ± 0.3 
ND 
LD6.4 ± 0.1 
AC-DODEG4 V3.9 ± 0.1 
LD8.2 ± 0.3 
ND 
LD12.0 ± 0.3 
OC-DODEG4 V3.8 ± 0.1 
LD9.4 ± 0.4 
V5.9 ± 0.1 
LD12.9 ± 0.2 
DO-DODEG4* V3.9 ± 0.1 ND 
L is the vesicle bilayer thickness (in nm), D the lamellar d-spacing (in nm). Standard errors 
on the fitted parameters are shown. Subscript v is data obtained for vesicles and LD is 
data obtained for LDs. ND = no stacks (multilamellar structure) determined. †M (the 
number of stacks in a multilayer structure) = 5, ‡ M = 4, in all other cases M = 20. 
 
 
 
 
 
Biophysical characterization of the lipoplexes 
Lipoplexes: photon correlation spectroscopy and zeta potential 
measurements 
As can be seen from Figure 2a, the apparent hydrodynamic size of 
the LD complexes varied from ~ 75 nm (LDs containing OC-DODEG4 
at a 2:1 charge ratio) to just over 200 nm (LDs containing TC-
DOesSEG3 at a 1:1 charge ratio), with most lipoplexes being in the 
approximate size range of 125 - 175 nm. As was observed with the 
LPDs there was no correlation between the size of the final LD and 
the structure of the cationic lipid it contained. Furthermore, while all 
LDs prepared at a L:D charge ratio of 2:1 exhibited a highly positive 
zeta potential, all the lipoplexes (regardless of cationic lipid 
structure) when prepared at a 1:1 charge ratio exhibited a negative 
zeta potential of between -9 and -22 mV (Figure 2b), suggesting that 
not all the negative charges of the DNA had been neutralized by the 
cationic lipid.  
 
Figure 2. (a) The apparent hydrodynamic size (nm) and (b) zeta potential 
(mV) of LDs, prepared from vesicles of the cationic lipids in combination 
with either DOPE or (*) DOPC and ctDNA at L:D charge ratios of either 
2:1 (grey bars) or 1:1 (black bars), respectively, and a ctDNA 
concentration of 1 µg/mL. All measurements were performed in 
triplicate at 298 ± 0.1 K on the day of preparation and are shown as the 
mean value ± standard deviation. 
 
 
 
(a) 
(b) 
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Lipoplex stability towards either PBS or Opti-MEM media was 
studied by establishing the variation in apparent hydrodynamic size 
(nm) over time of LDs prepared at a 2:1 L:D charge ratios and 
containing a selection of Group 1 and Group 2 lipids (Figure 3). Figure 
4, SI shows the apparent hydrodynamic size of a range of LDs at a 1:1 
and 2:1 charge ratio in the presence of Opti-MEM and FBS-containing 
media. Notably, the LDs were more stable in PBS than in Opti-MEM, 
with only LDs containing either of the TC-lipids, OC-DODEG4 and TC-
DOesDEG4 or DOTMA exhibiting a high degree of instability in PBS, 
increasing to more than a 1 μm in size over the 2 h incubation period 
(Figure 3). All other LDs tended to be much more stable under the 
conditions of the test. In contrast, most LD complexes incubated in 
Opti-MEM, and to a much lower extent FBS-containing media (Figure 
4 SI), increased their size over the same period, although it was 
noticeable that the LDs containing the DC lipids, DODEG4, DOesDEG4 
and DO-DOesDEG4, grew in size the least, suggesting that they 
produced the most stable LD complexes, probably due to the steric 
stabilising effect of the exposed n-EG chain.  
Figure 3. The variation in apparent hydrodynamic size (nm) of LDs, 
prepared from vesicles of the various lipids in combination with DOPE 
or (*) DOPC using ctDNA at L:D charge ratios of 2:1 in the presence of 
either (a) PBS or (b) Opti-MEM as a function of incubation time. 
Measurements were performed at a DNA concentration of 1 µg/mL for 
the LDs. All measurements were performed in triplicate at 298 ± 0.1 
K.and are shown as the mean value ± standard deviation. 
 
Lipoplexes: small angle neutron scattering 
The parameters used to obtain the best fit to the SANS data for all 
LDs prepared at a L:D charge ratio of 2:1 using ctDNA  prepared using 
Group 1 and 2 cationic lipids (measured at a cationic lipid 
concentration of 0.1 mg/mL) are shown in Table 2. It was not possible 
to model any of the LDs as comprising just single sheets (i.e. bilayers). 
Instead it was necessary to invoke the stack model to obtain a good 
fit to the SANS data, suggesting that the lipoplexes possessed 
repeating bilayers of lipid between which the DNA was 
intercalated12. Figure 3, SI gives an example of the SANS profile 
obtained for an LD prepared using vesicles of the dichain cationic 
lipid (Me-DOesDEG3) and DOPE and ctDNA along with the best fit to 
the data using the mixed sheet and stack model. Significantly, the 
thickness of the bilayer was much greater when the cationic lipids 
were part of a lipoplex, as opposed to when the lipids were in the 
form of vesicles. With the exception that LDs containing either 
DOTMA or DOTAP, where bilayer thickness did not change in the 
presence of DNA, the thickness of all the bilayers containing the DC 
lipids, including the methoxy capped DC lipids increased by up to 1.4 
nm in the presence of DNA, suggesting a significant re-arrangement 
of the lipids was necessary to accommodate the interaction of the 
cationic group with the negative charges on DNA. 
All TC lipids in Group 1 and Group 2 exhibited a much greater 
increase in bilayer thickness, with increases of ~ 4 - 5 nm being 
observed for the AC- and OC- lipids and in the range of 6 - 9 nm for 
the TC-lipids, again suggesting a significant structural re-
arrangement of the packing of lipids when in a lipoplex. However, it 
is not clear what the precise conformational arrangement of the 
lipids within the expanded ‘bilayer’ are, or indeed if the layer is still 
forming of a traditional bilayer. In this respect the repeat distances 
generally yielded a water layer in the approximate range of 1.6 -  1.9 
nm for the DC lipids and between 1.6 – 3.2 nm for the TC lipids. It is 
within this water layer that the DNA would be expected to reside. 
 
A re-arrangement of the same n-EG cationic lipids has been 
previously noted when the lipids were in lipopolyplexes (a complex 
of lipid, targeting peptide and DNA (LPD)).8 In this instance, however, 
the change in bilayer thickness was less, most probably because of 
the different structures adopted by the LD and LPD complexes. In 
contrast, previous SANS studies on vesicles and their corresponding 
LD and LPDs prepared using non-n-EG cationic lipids, including 
DOTMA and DOTAP (as also shown in our LD results in table 1) did 
not exhibit any discernable difference in bilayer thickness between 
the vesicles and LDs/LPDs,4-8 illustrating the effect of the presence of 
an n-EG group on packing in the gene delivery vehicles. 
 
Lipoplexes: transmission electron microscopy 
 
The LD complexes prepared using a selection of TC and DC (Group 1) 
lipids at a L:D charge ratio of 2:1 using ctDNA were visualised using 
negative staining transmission electron microscopy (TEM). A 
selection of the micrographs is shown in Figure 4. It was clear that, in 
the presence of DNA, the lipid vesicles had undergone a re-
arrangement to form either larger individual particles or large 
(a) 
(b) 
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clusters thereof, each of which possessed an electron-dense core, 
containing and surrounded by a regular repeating ‘‘lamellar-like’’ 
structure, believed to be composed of lipid layers, between which 
electrostatically-bound DNA was sandwiched. The presence of 
muiltilamellar structures for the LD complexes is in agreement with 
the results of the SANS study and the larger size of the lipopolexes 
compared to their parent vesicles measured by dynamic light 
scattering. Although the LDs were very polydisperse in size, there 
was no obvious difference between the nature or average size of 
structures containing the various cationic lipids. It is of note that no 
(uncomplexed) vesicles were detected by TEM in the LD complexes, 
suggesting that all of the lipid formed complexes. 
 
 
Figure 4. Transmission electron microscopy of LD complexes (lipoplexes 
prepared using ctDNA at a cationic lipid:DNA charge ratio of 2:1 made 
with (a) DODEG4; (b) DOesDEG4; (c) TC-DODEG4; (d) TC-DOesDEG4; (e) 
Me-DOesDEG3; (f) DOSEG3; (g) DOesSEG3; (h) TC-DOSEG3; (i) TC-
DOesSEG3; (j) Me-DOesSEG3. Size bar = 20 nm. 
 
Lipoplexes: picogreen fluorescence studies  
 
 Picogreen fluorescence studies were performed on both Group 1 
and 2 lipids in an attempt to study the effectiveness of the packaging 
of pDNA within the LD complexes at L:D charge ratios of between 
0.25:1 and 5:1 (Figure 5). As anticipated the interaction of the 
cationic lipids with DNA results in a reduction of the fluorescence 
intensity of picogreen, ultimately reaching a plateau (suggesting that 
maximum complexation had been reached for that complex). The 
lower the plateau fluorescence intensity reached, the stronger the  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Picogreen fluorescence binding assay showing pDNA 
packaging with LD complexes containing (a) Group 1 DOTMA lipids; (b) 
Group 2 DOTMA lipids; (c) Group 1 DOTAP lipids and (d) Group 2 DOTAP 
lipids and prepared with varying L:D charge ratios of 0.25:1-5:1. Relative 
fluorescence units (RFU) of the LD complexes were calculated as 
percentage fluorescence from free DNA. 
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DNA condensation13. For the LD complexes prepared using Group 1 
lipids, the plateau (or maximum complexation) was reached at a L:D 
charge ratio of between 2:1-3:1, while for the Group 2 lipids 
containing either an AC-or OC-third chain, the plateau was achieved 
at a slightly higher L:D charge ratio of between 3:1-4:1, suggesting 
that these lipids were not as effective at condensing pDNA. From a 
comparison of the value of the plateau in fluorescence intensities 
shown in Figure 5, it is also obvious that the long oleoyl chain TC-
lipids are more effective at complexing DNA than their corresponding 
DC-lipids; and that lipids in which the n-EG group was directly linked 
to the headgroup (i.e. DODEG4, TC-DODEG4, DOesDEG4 and TC-
DOesDEG4) were consistently better at condensing DNA compared 
to their corresponding lipids containing a cleavable linker (DOSEG3, 
TC-DOSEG3, DOesSEG3 and TC-DOesSEG3). It could be envisaged 
that the short n-EG chain (and potentially also the cleavable ester 
linker) may generate a thin hydrophilic barrier, resulting in a slightly 
greater distance between the cationic charge and the negatively 
charged DNA, resulting in a weaker interaction between the two 
oppositely charged moieties. In contrast, when a third chain is 
introduced on the terminal hydroxyl of an n-EG chain, the 
hydrophobic chain could be embedded in the lipid bilayer due to a 
hairpin bend in the oxyethylene chain, bringing the cationic charge 
closer to the anionic DNA and thereby facilitating their interaction. 
 
Lipoplexes: gel electrophoresis 
Gel electrophoresis was performed on the LD complexes prepared 
using the DC and TC lipids from Groups 1 and 2 at L:D charge ratios 
of 1:1 to 4:1 to determine the extent of complexation of pDNA 
(Figure 6). In agreement with the picogreen fluorescent study, the TC 
lipids of Group 1, were more effective at complexing pDNA than their 
DC equivalents, (indeed, even at the higher L:D charge ratio of 4:1, 
none of the DC lipids appeared to completely complex the DNA). 
Furthermore, lipids with the n-EG chain directly linked to the 
headgroup were also more effective at condensing DNA compared 
to their corresponding lipids containing the cleavable linker for 
reasons discussed above. DOTMA and DOTAP, however, still showed 
the best DNA complexation using this technique. Amongst the Group 
2 lipids, AC-DODEG4 and DO-DOesDEG4 were the most effective at 
complexing pDNA, with AC-DODEG4 being almost as effective as the 
TC lipids of Group 1.  
Figure 6. Gel condensation LDs prepared from (a) Group 1 and (b) Group 2 lipids 
with a 1:1 ratio of DOPE or *DOPC prepared at 1:1 to 4:1 charge ratio with DNA. 
 
Lipoplexes: in-vitro transfection  
 
The majority of transfections were performed in rat neuroblastoma 
B104 cells. This cell line was selected as it is intended to use the 
lipoplexes produced in the present study for the treatment of 
neurodegenerative diseases. Specifically the lipoplexes will be 
delivered to the brains of rats via convection enhanced delivery. LDs 
prepared from mixing vesicles containing either a TC lipid, or the 
corresponding DC analogue, in the presence of a 1:1 molar ratio of 
DOPE with gWiz plasmid DNA in either a 1:1 or a 2:1 L:D charge ratio 
(Figure 7) were tested. The LDs were prepared in Opti-MEM thereby 
allowing a comparison with the results of other groups14,15. Note, 
that although we include only one set of transfection experiments 
here, these experiments were repeated on at least 3 occasions: while 
the absolute values obtained for transfection efficiency varied, the 
trends observed between data sets were consistent. A similar trend 
of transfection behaviour to that obtained in B104 cells was seen in 
mouse neuroblastoma N2A cells. Although higher absolute levels of 
transfection were achieved (Figure 5 SI), higher cytotoxicity (as 
assessed by the protein content after exposure of the cells to the 
lipoplexes) was also seen in this cell line as shown in Figure 6 SI.  
Surprisingly, there was little difference observed between the 
transfections obtained with LDs prepared at the two charge ratios. 
Other trends included that regardless of the number of hydrocarbon 
chains present, LD complexes prepared using the ether lipids, i.e. the 
‘DOTMA’ series, exhibited higher transfections than those containing 
ester lipids, i.e. the ‘DOTAP’ series. Most significantly in the present 
study, LD complexes prepared using TC-lipids composed of three C18 
chains (i.e. TC-DODEG4, TC-DODEG3, TC-DOesDEG4, TC-DOesEG3) 
exhibited a reproducibly higher level of transfection than their 
corresponding DC-chain lipids (DODEG4, DODEG3, DOesDEG4, 
DOesEG3). In addition, they were superior transfection agents 
compared to Lipofectamine and LD complexes containing either 
DOTMA or DOTAP. Capping the terminal hydroxyl of a DC-lipid with 
a methyl group had the effect of slightly increasing the transfection 
ability (Me-DOesDEG4, Me-DOesEG3) but not to the extent achieved 
using long oleoyl chain TC lipids. Interestingly, when considering the 
Group 2 ‘DOTMA’ lipids, addition of an acetyl group (AC-DODEG4) 
appeared beneficial to the transfection, but not as beneficial as the 
addition of an octanoyl chain (OC-DODEG4). Surprisingly, 
lengthening of the chain attached to the terminal hydroxyl group to 
dodecanoyl (DO-DODEG4) was observed to virtually abolish any 
transfection, although this may have been predominantly due to 
the need to replace DOPE with DOPC when preparing the parent 
vesicles. 
The  cytotoxicity exhibited by the B104 cells after their 
incubation  with the LDs for 4 h was assessed by determining total 
protein content after removal of dead cells and media via a 
thorough washing of the cells. The results were compared with 
those obtained after 4 h incubation with Lipofectamine, where a 
viability of 72% was achieved. Significantly, when Lipofectamine 
2000 was used for transfection, severe reductions in cell viability, 
were observed and as a consequence, in the present study, 
Lipofectamine 2000 was not used as a standard. The results of the 
study determining protein content of the B104 cells after incubation 
with the LDs are shown in Figure 7, SI).  When incubated with 
              AC-DODEG4                OC-DODEG4            AC-DOesDEG4            DODOesDEG4* 
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lipoplexes prepared at a 1:1 lipid:DNA charge ratio, the cells 
exhibited a cell viability of greater than 85% when compared to an 
untreated control. In contrast, incubation of the B104 cells with 
lipoplexes prepared at a 2:1 charge ratio resulted in lower cell 
viabilities of between 38%-92%. LDs containing TC lipids at the 2:1 
charge ratio exhibited a reduction in cell viability, which was greatest 
with the ester (DOTAP) series of lipids, specifically TC-DOesDEG4 and 
TC-DOesSEG3. In addition, incubation with LDs containing either the 
Group 2 lipids AC-DODEG4 and OC-DODEG4, or the methoxy capped 
lipids, Me-DOesDEG4 and Me-DOesEG3, at a 2:1 charge ratio also 
resulted in lower cell viabilities.  
 
 
Figure 7. In vitro transfection efficiency (expressed as RLU/mg protein) of LD 
complexes prepared in Opti-MEM at 1:1 (grey bars) and 2:1 (black bars) lipid:gWiz 
plasmid DNA charge ratio in B104 cells. Cationic lipid used to prepare the LDs 
shown on the abscissa. All the lipids were formulated at a 1:1 ratio with DOPE or 
(*)DOPC. Data is the mean of three measurements ± standard deviation. 
 
Discussion 
 
The present study focused on determining the structural and  
formulation requirements necessary for obtaining high levels of in 
vitro transfection activity using LDs prepared from a series of novel 
TC cationic lipids, compared to the corresponding DC lipids. In order 
to understand what effect the presence of an additional, third 
hydrophobic chain has on the biophysical properties of the LD 
complexes, and whether any differences in their biophysical 
properties could be correlated with differences in transfection, 
several biophysical experiments have been performed. Although no 
differences in the size and shape of the LDs formed by the DC and TC 
lipids could be observed by TEM, small angle neutron scattering 
studies showed that there was a significant conformational re-
arrangement of the lipid bilayer, particularly in the LD complexes 
prepared using TC lipids possessing a long third alkyl chain. It is 
thought that this rearrangement was necessary to allow the positive 
charge on the cationic lipid to interact effectively with the negatively 
charged DNA.16 Studies have been carried out to investigate whether 
n-EG DC cationic lipids undergo such a rearrangement to enable the 
cationic moiety to interact with the negatively charged phosphate on 
the DNA.17,18 Indeed the presence of the n-EG group in the DC lipids 
is thought to introduce a degree of steric repulsion which hinders the 
electrostatic interaction between the cationic lipid headgroup and 
DNA (as evidenced by gel electrophoresis and picogreen results 
conducted using PEG-2000 lipids19). This combination of forces could 
lead to the slight protrusion of the cationic lipids in the DC-lipid:DOPE 
bilayer, resulting in an overall thicker bilayer (as proposed in the 
schematic diagram in Figure 8). In the case of the TC lipid-containing 
bilayers, which were prepared in combination with DOPE or DOPC 
during vesicle formation, the third acyl chain may be embedded in 
the lipid ‘bilayer’ through folding of the n-EG chain, especially since 
no increase in bilayer thickness or multilamellar structures have been 
observed in vesicles alone, compared to the corresponding DC lipids 
in SANS studies. In the case of LD complexes, however, the dramatic 
increase in bilayer thickness for all the TC lipid systems suggests 
major rearrangements in the lipid bilayers. The thickness of all the TC 
lipids is around twice that of their corresponding DC lipids. This could 
suggest that, on average, two bilayers become inter-digitated with 
the third chain from a lipid in one bilayer being inserted into an 
adjacent bilayer, and held in place by an n-EG bridge (Figure 8). 
Indeed several studies20,21 have proposed that the first step in 
lipoplex formation involves coating of the vesicles with DNA, 
followed by interaction with a second DNA-coated vesicle. 
Afterwards, the two vesicles either fuse or break and roll over each 
other19. It is therefore possible that during this re-arrangement 
process, the insertion of the third chain into an adjacent bilayer can 
occur. 
It should be noted that the increase in bilayer thickness in TC-lipid 
lipoplexes (as suggested by the SANS measurements) was not 
detected in TEM images (figure 4). This is most likely a consequence 
of the resolution limitations of the imaging instrument, or the 
presence of the negative stain which might not differenciate 
between a normal and an itnerdigitated bilayer. The proposed model 
in Figure 8 was therefore based predominantly on the SANS results. 
  
Figure 8. Proposed structural re-arrangement of DC and TC lipids during lipoplex 
formation. 
The in vitro transfection efficacies of LDs prepared from TC-lipids 
(especially those possessing a long third acyl chain) were found to be 
consistently higher than their DC analogues. Whether this difference 
in transfection is due to the n-EG chain protruding out in the case of 
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DC lipids (therefore hindering cellular internalisation and trafficking 
as most studies have reported when using PEGylated lipids22) as 
opposed to being folded due to the embedding of the third chain, in 
the case of the TC lipids is unknown at present. However, all the TC-
lipid containing lipoplexes also showed significantly better 
transfection (at least 2-3 fold higher) compared to DOTMA and 
DOTAP, which do not contain any oxyethylene groups. This suggests 
that different factors contribute to their superiority. Since the 
picogreen fluorescence and gel electrophoresis studies showed that 
the TC lipids were most effective at complexing DNA, it is thought 
that DNA complexation could play a major role in their enhanced 
transfection efficiency. In addition, it it is possible that the ‘third’ lipid 
chain may insert into the endosomal membrane, thereby mediating 
endosomal release and further enhancing transfection. 
TC-lipids containing a short third alkyl chain, although not as effective 
as their long chain counterparts were more effective than the 
corresponding DC lipids. An interesting exception to these 
observations was seen with the LDs containing OC-DODEG4 which 
did not show a strong binding of DNA but did exhibit a good level of 
transfection. In summary, the TC-lipids reported here show 
interesting in vitro transfection properties and potentially a new class 
of transfection agents for non-viral gene delivery. 
 
Experimental  
 
Detailed experimental procedures, characterisation data, and 
Supplementary Figures S1-S6 are in the Supplementary Information.  
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